Case 6 Manzhu Kang, Phil Soto, Ivana Olguin California State University, Los Angeles.

Slides:



Advertisements
Similar presentations
Immunodeficiency K.J. Goodrum Origins of Immunodeficiency Primary or Congenital –Inherited genetic defects in immune cell development or function,
Advertisements

Primary deficiencies of the complement system Radana Zachová Institute of Immunology Faculty hospital Prague, Motol.
Primary Immunodeficiency Conleth Feighery Dept. of Immunology 3 rd Med February 2010.
X- linked agammaglobulinemia Versailles, France October 22, 2004 INGID.
Background on Zap70 SCID Slides from Arthur Weiss GEMS Journal Club August 2012.
Final Case Study: Case #3 Rabin Anouseyan Alex Huynh Kimberly Rampasan California State University, Los Angeles Department of Biological Sciences.
Asymptomatic hypogammaglobulininemic patients Do we need immunoglobulins? Jiří Litzman, Marcela Vlková, Maria Šárfyová Dept Clin Immunol Allergol, Masaryk.
How is antibody diversity generated? Two early theories: Germline hypothesis The genome contains many loci encoding antibody molecules. B cells express.
Immunodeficiency K.J. Goodrum Origins of Immunodeficiency Primary or Congenital –Inherited genetic defects in immune cell development or function,
MICR 304 Immunology & Serology
Primary Immunodeficiency Conleth Feighery Dept. of Immunology MSc in Molecular Medicine 2009.
Unit 1 Nature of the Immune System Part 7 Immunodeficiency Diseases
Chapter 17 Chronic Leukemias.
Immunodeficiency: Primary immune deficiency: -Caused by intrinsic or congenital defects. -Over 100 diseases of this type are known in humans, and for many.
The Wiskott-Aldrich Syndrome: An X-linked Primary Immunodeficiency
Diagnosis of Primary Immunodeficiency
O THER MALIGNANT LYMPHOPROLIFERATIVE DISORDERS The lymphomas and plasma cell problems.
Primary Immunodeficiency Disorders (PID) Soheila Alyasin M.D. AssOCIAT Professor of Pediatrics Division of Immunology and Allergy.
Malignancy  NHL 7.7% - mostly extranodal, all B cell type  Others - –Waldenstrom’s macroglobulinemia –Hodgkin’s disease –Adenocarcinoma - stomach, ovary,
Child with hematological dysfunction Emad Al Khatib, RN,MSN,CNS.
Specific Defense Mechanisms – The Immune System
Lecture 14 Immunology: Adaptive Immunity. Principles of Immunity Naturally Acquired Immunity- happens through normal events Artificially Acquired Immunity-
Hemophilia Research Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, MASA What is: Hemophilia is an X-linked congenital bleeding disorder.
Chapter 8: Genetic Engineering by Mailee Phet by Mailee Phet My Hoa Nguyen.
制作人: 董天一 付金秋 李玉叶 齐霞风 王 哲 相晓娟 赵 静 朱 莎 CASE STUDY A 29-year-old man had a history of cough, sputum and hemoptysis for 22 years. The disease outbreaks.
A Patient with Recurring Infections Julia Wright, M.D. Clinical Associate Professor of Medicine Section of General Internal Medicine.
How much gammaglobulin ? INGID VII th Meeting Budapest, October 7, 2006 Rolf Gustafson.
VILNIUS UNIVERSITY HOSPITAL SANTARISKIU KLINIKOS.
IMMUNODEFICIENCY Lecture Outlines Define immunodeficiency
Principle of Single Antigen Specificity Each B cell contains two copies of the Ig locus (Maternal and Paternal copies) Only one is allowed to successfully.
Primary antibody deficiencies in Estonia Sirje Velbri Tallinn Childrens’ Hospital, Estonia.
Immunology Innate - Adaptive Immunity Specificity Memory Tolerance.
Genetics Hemophilia Presentation By Will Mcauliffe-Trefz-Genetics.
P-CID patient discussion form. Patient summary y/o boy/girl with: – Infection – Immune dysregulation – T cell deficiency Consanguinity: Family history:
Immunology Chapter 21 Richard L. Myers, Ph.D. Department of Biology Southwest Missouri State Temple Hall 227 Springfield, MO
Chapter 18 AIDS and other Immunodeficiences Dr. Capers
Immunodeficiency.
B Cell Development Learning Objectives for Lecture 11
2nd Year Medicine- IBLS Module May 2008 IBLS Lecture 11 White Blood Cells (Leucocytes)
The Study Of Frequency Of Primary ImmunoDeficiency Disorders In Iran And Constructing A Database For Registering The Patients.
Immune deficiency disorders Dr. Hend Alotaibi Assistant professor & Consultant College of Medicine, King Saud University Dermatology Department /KKUH.
ANTIBODIES Agents of Immunity - A Guide for Teachers - Prepared by Johanna Mancini for Immunology Montreal August 2008.
Antigens Immunogen – a molecule that specifically interacts with an antibody or lymphocyte and elicits an immune response Antigenic determinants (epitopes)
White blood cells and their disorders Dr K Hampton Haematologist Royal Hallamshire Hospital.
PID patients in Motol Radana Zachová Institute of Immunology University hospital Prague Motol, Czech Republic ESID Prague Spring meeting 2005.
Hypersensitivity, Autoimmunity and Immunodeficiency Part III Nancy L Jones, MD August 29, 2011.
Humoral immunity Antibody structure Antibody diversity
Hemophilia By: Olivia Holman, Oscar Sierras Jaimes and Daniel Barnett.
Immune deficiency disorders
Immune-deficiencies for batch 17-MBBS Yr 1 Dr. P. K. Rajesh. M.D.
IMMUNODEFICIENCY DISORDERS
Immunodeficiency: Antibody
Effector Mechanisms of Humoral Immunity
ADAPTIVE IMMUNITY: B CELLS AND ANTIBODIES
Primary immunodeficiencies in adults (Lithuanian experience)
Immunodeficiency Diseases:
Immunodeficiency disorders
Development of B lymphocytes
B Cell Development in Bone Marrow and Peripheral Lymphoid Tissue: Part 1 March 20, :00-12:00.
USMLE Step 1 Immunology.
Primary Immunodeficiency Disorders
Immunodeficiency: Primary immune deficiency:
Immunoglobulin Expression and the Role of Antigen in
Antibody production and B cell differentiation
What does this protein make up or do?
CVID- Major features Recurrent pyogenic infections, with onset at any age Increased incidence of autoimmune disease Total immunoglobulin level < 300 mg/dL.
Marc C. Levesque, MD, PhD, E. William St. Clair, MD 
Immunodeficiency disorders
Immune System Helm’s (probably way too….) Short Version.
Introduction to Microbiology
Presentation transcript:

Case 6 Manzhu Kang, Phil Soto, Ivana Olguin California State University, Los Angeles

 Clinical manifestations :  Recurrent Pneumonia, otitis media, erysipelas since 2 years old.  Atelectasis, chronic cough, no visible tonsil, moist crackles at both lung bases at age of 9.  Lab Results :  Very low level of IgG and IgM, no IgA, normal white blood cell count  Family History :  2 brothers of his mother died from pneumonia at age of 2, but 2 healthy sisters who have a healthy son and daughter  One younger sibling with similar symptoms

 Recurrent infections since age of 2  Very low level of serum immunoglobulins  Absent tonsils  Family history

X-linked Agammaglobulinemia

 Immunoelectrophoresis reveals the absence immunoglobulin in serum  B cells level in the peripheral blood by flow cytometry with no or very little B cells  Genetic testing to detect mutation in X- chromosome

 Immunoglobulin replacement by weekly subcutaneous injection or intravenous infusion every 2-4 weeks, for life.  Chronic prophylactic antibiotics are used in some centers for prevention of secondary complications (Howard, et al. 2006).

 When intravenous gammaglobulin became available, the incidence of chronic enteroviral infection has markedly decreased in individuals with XLA.  As a result of earlier diagnosis, more liberal use of antibiotics, and the development of preparations of gammaglobulin that allow normal concentrations of serum IgG to be achieved, most individuals lead a normal life and may live well into their fifties (Howard, et al. 2006).

 Your results show that you have a genetic disease called x-linked agammaglobulinemia. It primarily affects boys that's why you and your brother are so sick all the time.The disease causes you to be unable to produce antibodies that make up gamma globulins in your blood.  This inherited disease caused you to become very sick since you were unable to fight off infections. Luckily, we have medicine that can make you better and only involves one shot every two to four weeks,Do you have any questions?

 Btk is a protein expressed in B cell development which is involved in signal transduction and is involved in signaling the development of B cells if they are able to transiently express the heavy chain and light chain in the cell.  A defect in Btk would cause B cell development to be incomplete and stopped at the pre-B cell step  Without maturation, B cells are not differentiated or sent to the lymph nodes which results in the lack of tonsils  When B cells mature they become plasma cell and release antibodies which have multiple functions  Antibodies can be involved in opsonization, neutralization, activating complement and blocking bacteria from attaching to epithelial cells B cell precursor Rearrangement of Ig genes Immature B cell Negative selection Mature B cell Migration to peripheral lymphoid organs Activated B cell Plasma CellMemory B cell

 The objective was to investigate whether or not the alterations in the phagocytosis of monocytes in XLA patients was due to number of complement and Fcg receptors  Patients with XLA, CVI and healthy patients’ monocytes were analyzed by flow cytometry for complement receptors and Fcg receptors  CVI is a disease which prevents B cell differentiation and ability to produce antibodies but B cells are at normal levels  Found that XLA patients show the same or higher percentage of monocytes expressing Fc ɤ and CR receptors  Findings support idea the inefficient chemotaxis and phagocytosis in XLA patients are not due to deficient receptors but rather defects in cytoplasmic transduction mechanisms, a result of the Btk defect

Critiques: The sample size is small and all patients are on immunoglobulin therapy which could possibly result in an increase in expression of receptors

 X-linked agamaglobulinemia results from a defect in Btk which causes a signal transduction defect that does not allow B cells to develop past the pre- B cell stage resulting in no antibody production  Typical symptoms are recurrent pyogenic infections, ear infections, lung infections after infancy(nursing), missing tonsils, missing adenoids, pneumonia  No way to cure at this time, lifelong injection of immunoglobulins  With the development of immunoglobulin therapy it is possible to live a normal life

 Moschese, V., Orlandi, P., Di Matteo, G., Chini, L., Carsetti, R., Di Cesare, S., et al. (2004). Insight into B cell development and differentiation. Acta Paediatrica, Retrieved from Academic Search Premier database.  Amoras, A., da Silva, M., Zollner, R., Kanegane, H., Miyawaki, T., & Vilela, M. (2007). Expression of Fc γ and complement receptors in monocytes of X-linked agammaglobulinaemia and common variable immunodeficiency patients. Clinical & Experimental Immunology, 150 (3), doi: /j x.  Howard V, Greene JM, Pahwa S, Winkelstein JA, Boyle JM, Kocak M, Conley ME. The health status and quality of life of adults with X-linked agammaglobulinemia. Clin Immunol. 2006; 118: 201–8. [PubMed]